Drug intelligence / Profile preview

hucMSC-derived exosomes

Development stage
Preclinical
Lead developer
Hebei Medical University
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

hucMSC-derived exosomes (HucMSC-Exos) are extracellular vesicles, typically ranging from 30 to 150 nm in diameter, secreted by human umbilical cord mesenchymal stem cells (hucMSCs). These vesicles serve as a biologic therapeutic modality that facilitates intercellular communication by delivering a complex cargo of proteins (such as insulin and superoxide dismutase 1), mRNAs, and microRNAs (notably miR-133b) to recipient cells. In the context of Parkinson's disease, HucMSC-Exos have demonstrated the ability to cross the blood-brain barrier and reach the substantia nigra, where they exert neuroprotective effects by inducing autophagy and inhibiting the apoptosis of dopaminergic neurons. Preclinical research suggests their therapeutic potential across a wide spectrum of conditions, including type 1 diabetes, liver fibrosis, acute kidney injury, wound healing, and myocardial infarction, primarily through anti-inflammatory and regenerative mechanisms.

Other names
human umbilical cord mesenchymal stem cell-derived exosomeshucMSC-Exo
02

Targets

BECN1 (Beclin-1)CASP3 (Caspase-3)MAP1LC3A

Beyond the preview

Go deeper on hucMSC-derived exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hucMSC-derived exosomes.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call